ARNAS GAIXOTASUNAK
Hospital Clinic Barcelona
Barcelona, EspañaHospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (47)
2024
-
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Scientific reports, Vol. 14, Núm. 1, pp. 12726
-
Cost-Sensitive Ordinal Classification Methods to Predict SARS-CoV-2 Pneumonia Severity
IEEE Journal of Biomedical and Health Informatics, Vol. 28, Núm. 5, pp. 2613-2623
-
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
ERJ Open Research, Vol. 10, Núm. 1
-
Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery
Open Respiratory Archives, Vol. 6, Núm. 3
-
Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial
Chest, Vol. 165, Núm. 3, pp. 673-681
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques
PLoS ONE, Vol. 18, Núm. 4 April
-
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Frontiers in Medicine, Vol. 10
-
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
International Journal of COPD, Vol. 18, pp. 2473-2481
-
Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
Microorganisms, Vol. 11, Núm. 11
-
Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors
Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82
-
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism
American Heart Journal, Vol. 257, pp. 62-68
2022
-
Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis
Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283
-
Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
Chest, Vol. 162, Núm. 4, pp. 768-781
-
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734
2021
-
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 6, pp. 1075-1085